Compare DexCom, Inc. (DXCM) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs J B Hunt Transport Services Inc — how do they compare? DexCom, Inc. trades at $77.8 (market cap $28.06B), while J B Hunt Transport Services Inc trades at $291.63 (market cap $26.04B). The key difference: DexCom, Inc. and J B Hunt Transport Services Inc are close in size by market cap, and J B Hunt Transport Services Inc pays a 0.65% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | JBHT | |
|---|---|---|
Market Cap | $28.06B | $26.04B |
Sector | Health | Industrials |
52-Week High | $89.53 | $290.07 |
52-Week Low | $54.84 | $130.65 |
Enterprise Value | $27.03B | $27.18B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
JBHT trades at $280.87, down 0.75% today but maintains strong momentum with four consecutive quarterly earnings beats. The stock shows bullish technical signals with moving averages supporting upward trends, while fundamentals reveal solid profitability with 5.13% net margin and 16.68% ROE. Recent Q2 2026 results exceeded expectations with EPS of $1.91 on $3.5 billion revenue, driven by intermodal growth and cost reductions.
Outlook remains positive with analyst consensus at Buy (57.8%) and $289.38 price target, though elevated P/E of 39.29 poses valuation concerns. Key risks include freight market volatility and rising operational costs, but strong institutional support and record shareholder returns provide stability for continued growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
